Associate ProfessorJames Wilmott

Program founder and leader, establishing and directing large‑scale translational cancer immunology programs with national and international impact

 

Institutional leadership through service on research, education and advisory committees, including Cancer Council NSW research governance and major university advisory boards

 

Builder and leader of multidisciplinary teams, spanning genomics, immunology, pathology, clinical trials, data science and consumer engagement

 

National and international service as advisor to collaborative consortia and contributor to clinical trial design, biomarker frameworks and guideline development

 

Peer‑review and funding panel service for major national and international funding bodies, shaping research investment priorities

 

Strategic infrastructure leadership, contributing to planning and implementation of advanced genomics, single‑cell and spatial biology platforms

 

Commitment to community and consumer engagement, embedding consumer voices in research governance, study design and implementation